XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 1 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,901 | -15.5% | 1,022,040 | +19.0% | 0.00% | 0.0% |
Q2 2023 | $2,250 | +128.7% | 858,694 | +42.2% | 0.00% | +200.0% |
Q1 2023 | $984 | +48.4% | 603,894 | +21.1% | 0.00% | 0.0% |
Q4 2022 | $663 | -99.9% | 498,494 | -9.3% | 0.00% | 0.0% |
Q3 2022 | $858,000 | -13.4% | 549,694 | -14.6% | 0.00% | 0.0% |
Q2 2022 | $991,000 | -44.1% | 643,694 | -7.1% | 0.00% | -50.0% |
Q1 2022 | $1,774,000 | -31.2% | 692,994 | -21.3% | 0.00% | -33.3% |
Q4 2021 | $2,579,000 | – | 880,194 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |